Brewin Dolphin Wealth Management LTD Dynavax Technologies Corp Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 2,500 shares of DVAX stock, worth $27,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$27,850
Previous $27,000
14.81%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
259Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$244 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$121 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$88.7 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$79.6 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.41B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...